Healthcare Professionals

REDUCE LAP-HF Clinical Program

Corvia Medical has conducted multiple REDUCE LAP HF studies around the world to evaluate the Corvia Atrial Shunt System for the treatment of HF patients with left atrial pressure who remain symptomatic despite standard Guideline Directed Medical Therapy (GDMT).

Studies include the following:

To learn more about the REDUCE LAP-HF studies
visit www.clinicaltrials.gov